Membership
Our Work
Resources
- Resource LibraryWhitepapers, research, toolkits, and more
- Video LibraryLearn about upcoming webinars or watch them on-demand
News & Events
- News & EventsMDIC helps you stay abreast of the latest advances and happenings within the MedTech sector through news releases and educational events. Check out the MDIC activities and events as well as a compilation of must-attend meetings and conferences from across the industry.
- containt-menu
  - EventsMDIC hosts in-person and virtual forums and events for the benefit of the medical technology community….
  - NewsGet the scoop on what’s new at the consortium and across the medical device industry.
  - MDIC Innovators Forum
About
- About MDICFounded in 2012, the Medical Device Innovation Consortium (MDIC) is the first Public-Private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle.
- containt-menu
  - Mission & PurposeFrom research to innovation, explore our story.
  - LeadershipMeet the MDIC Board of Directors.
  - StaffGet to know our team.
  - CareersEmployment opportunities with MDIC.
Contact

MDIC In the News: Andy Fish Welcomes Dr. Michelle Tarver as the New Director at FDA’s CDRH

October 24, 2024 | News

Michelle Tarver Is Officially the New Leader at FDA's Center for Devices and Radiological Health

The FDA has appointed Dr. Michelle E. Tarver as the permanent Director of its Center for Devices and Radiological Health (CDRH). An ophthalmologist with a doctorate in epidemiology, Dr. Tarver has been with the FDA since 2009, holding key leadership roles such as Deputy Director for Transformation at CDRH. She has served as Acting Director since July 2024, following Dr. Jeff Shuren’s retirement.

Dr. Tarver has consistently championed patient-centered approaches, emphasizing health equity and quality across the total product lifecycle. Her leadership has strengthened collaboration and transparency within the FDA, ensuring patient perspectives play a critical role in regulatory processes.

In an article by MD+DI, MDIC expressed strong support for Dr. Tarver’s appointment, recognizing her visionary leadership and dedication to improving patient care. MDIC President and CEO Andrew C. Fish noted that her focus on collaboration and innovation aligns with MDIC’s mission to advance regulatory science and enhance patient outcomes.

Read here